Newsroom

Sorted by: Latest

-

CarMax Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CarMax, Inc. - KMX

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into CarMax, Inc. (NYSE: KMX) (“CarMax” or the “Company”).On September 25, 2025, the Company announced its second quarter Fiscal Year 2026 financial results, disclosing, among other things, that retail unit sales had decreased 5.4%, comparable store unit sales had decreased 6.3...
-

TotalEnergies SE UK Regulatory Announcement: Director/PDMR Shareholding

PARIS--(BUSINESS WIRE)--  Notification and Public Disclosure of transactions by Persons Discharging Managerial Responsibilities TotalEnergies SE has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the UK Market Abuse Regulation. About TotalEnergies TotalEnergies is a global integrated energy company that produces and markets ene...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NASDAQ Clean Edge Green Energy UCITS ETF 26.03.2026 QCLN.LN IE00BDBRT036 975,002.00 USD 17,143,751.11 17.583  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Innovative Transaction & Process UCITS ETF 26.03.2026 LEGR LN IE00BF5DXP42 1,000,002.00 USD 46,955,483.86 46.955  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 26.03.2026 LANDXN.LN IE000RN036E0 34,035.00 USD 677,780.19 19.914  ...
-

Riassunto: Biocytogen annuncia l'approvazione IND da parte dell'FDA per NEOK002, un farmaco prodotto dall'azienda partner NEOK Bio per la cura dei tumori solidi

PECHINO--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), un'azienda biotecnologica globale che promuove la ricerca e lo sviluppo di nuovi farmaci a base di anticorpi con tecnologie innovative, oggi ha annunciato che la sua azienda partner NEOK Bio, Inc. ha recentemente ottenuto l'approvazione da parte della statunitense Food and Drug Administration (FDA) della domanda per un nuovo farmaco sperimentale (IND) relativa a NEOK002, un programma...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 26.03.2026 LANDXEN.LN IE000C75IMX8 15,878.00 USD 288,465.12 18.168  ...
-

Equitable Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Equitable Holdings, Inc. - EQH

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Equitable Holdings, Inc. (NYSE: EQH) and Corebridge Financial, Inc. (NYSE: CRBG). Under the terms of the agreement, each outstanding share of Equitable common stock will be exchanged for the right to receive 1.55516 shares of the new parent company’s common stock, and upon completion of the proposed transact...
-

Biocytogen annonce l’autorisation d’une demande IND pour le médicament NEOK002 ciblant les tumeurs solides, de son partenaire NEOK

PÉKIN--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), une entreprise mondiale de biotechnologie qui se consacre à la recherche et au développement de nouveaux médicaments à base d’anticorps en utilisant des technologies innovantes, a annoncé aujourd’hui que son partenaire NEOK Bio, Inc. a obtenu l’autorisation de la Food and Drug Administration (FDA) des États-Unis pour une demande d’investigation de nouveau médicament (IND) pour NEOK002,...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Smart Grid Infrastructure UCITS ETF 26.03.2026 GRDU.LN IE000J80JTL1 28,150,002.00 USD 1,579,901,771.70 56.124  ...